The Computer Automated Structure Evaluation System (CASE) was used to identify the structural components responsible for either the mutagenicity or the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs). These were found not to overlap and some of the structural components were endowed with much more biological activity than others.
A study was then undertaken to determine whether these structural features could explain the mutagenicity and carcinogenicity of 7,12-dimethylbenz(a)anthracene (DMBA). It was found that the structures identified by CASE could explain the mutagenicity and carcinogenicity qualitatively as well as quantitatively. Moreover, the identified structures were entirely consistent with recent findings on the metabolism and DNA adduct formation of DMBA.
These results are taken to indicate that CASE can be used to identify the structures in a molecule (e.g., PAH) that are sites of metabolism. Laboratory studies can then focus on that portion of the molecule.
References
1.
1. Klopman, G., and Rosenkranz, H. S. (1984). Structural requirements for the mutagenicity of environmental nitroarenes.Mutat. Res.126, 227–238.
2.
2. Rosenkranz, H.S., and Klopman, G. (1987). Computer automated structure evaluation of the carcinogenicity of N-nitrosothiazolidine 4-carboxylic acid.Food Chem. Toxicol.25, 253–256.
3.
3. Klopman, G., Frierson, M.R., and Rosenkranz, H. S. (1985). Computer analysis of toxicological databases: Mutagenicity of aromatic mines in Salmonella testers strains.Environ. Mutagen.7, 625–644.
4.
4. Klopman, G., Contreras, R., Rosenkranz, H.S., and Waters, M. D. (1985). Structure—genotoxic activity relationships of pesticides: Comparison between the results of several short-term assays. Mutation Res.147, 343–356.
5.
5. Klopman, G., Kalos, A., Frierson, M., and Rosenkranz, H. S. (1986). Nppd (spy dust) is predicted to be a mutagen.Environ. Mutagen.8, 627–630.
6.
6. Rosenkranz, H.S., and Klopman, G. (1988). Case, the computer automated structure evaluation system as an alternative to extensive animal testing.Toxicol. Ind. Health4, 533–540.
7.
7. Klopman, G., Kalos, A.N., and Rosenkranz, H. S. (1987). An artificial intelligence study of the structure—activity relationships of non-fused ring nitroarenes and related compounds.Mol. Toxicol.1, 61–81.
8.
8. Rosenkranz, H.S., and Klopman, G. (1986). Mutagens, carcinogens and computers. In: Ramel, C., Lambert, B., and Magnusson, J., eds. Genetic Toxicology of Environmental Chemicals Part A: Basic Principles and Mechanisms of Action. New York: Alan R. Liss, pp. 71–104.
9.
9. Rosenkranz, H.S., and Klopman, G. (1988). Case, The Computer Automated Structure Evaluation Method, correctly predicts the low mutagenicity for Salmonella of nitrated cyclopenta-fused polycyclic aromatic hydrocarbons.Mutat. Res.199, 95–101.
10.
10. Rosenkranz, H.S., Mitchell, C.S., and Klopman, G. (1985). Artificial intelligence and Bayesian decision theory in the prediction of chemical carcinogens.Mutat. Res.150, 1–11.
11.
11. Rosenkranz, H.S., Klopman, G., Chankong, V., Pet-Edwards, J., and Haimes, Y. Y. (1984). Prediction of environmental carcinogens: A strategy for the mid 1980's.Environ. Mutagen.6, 231–258.
12.
12. Klopman, G., Macina, O.T., Levinson, M.E., and Rosenkranz, H. S. (1987). Computer automated structure evaluation of quinolone antibacterials.Antimicrob. Agents Chemother.31: 1831–1840.
13.
13. Klopman, G., and Macina, O. T. (1985). Use of the computer automated structure evaluation program in determining quantitative structure—activity relationships within hallucinogenic phenylalkylamines.J. Theor. Biol.113, 637–648.
14.
14. Klopman, G., Macina, O.T., Simon, E.J., and Hiller, J. M. (1986). Computer automated structure evaluation of opiate alkaloids.J. Mol. Struct.134, 299–308.
15.
15. Klopman, G., and Macina, O. T. (1987). Computer automated structure evaluation of antileukemic 9-anilinoacridines.Mol. Pharmacol.31, 457–476.
16.
16. Klopman, G., and Kalos, A. (1986). Quantitative structure—activity relationships of beta-adrenergic agents. Application of the computer automated structure evaluation (Case) technique of molecular fragment recognition.J. Theor. Biol.118, 199–214.
17.
16a. Rannug, A., Rannug, U., Rosenkranz, H.S., Winqvist, L., Westerholm, R., Agurell, E., and Grafstrom, A.-K. (1987). Certain photooxidized derivatives of tryptophan bind with a high affinity to the Ah receptor and are likely to be endogenous signal substances.J. Biol. Chem.,262, 15422–15427.
18.
17. Klopman, G., And Venegas, R. E. (1986). Case study of in vitro inhibition of sparteine monooxygenase.Acta Pharmacol. Jug.36, 189–209.
19.
18. Nesnow, S., Bergman, H., Bryant, B.J., Helton, S., and Richard, A. (1988). A Case-Sar study of mammalian hepatic azoreduction.J. Toxicol. Environ. Health.24, 499–513.
20.
19. Woods, S.W., and Mass, M. J. (1988). Retinoid structure—activity analysis. Environ. Mol. Mutat. Suppl. 11, 11, 114.
21.
20. Frierson, M.R., Klopman, G., and Rosenkranz, H. S., (1986). Structure—activity relationships among mutagens and carcinogens: A review.Environ. Mutagen.8, 283–327.
22.
21. Yuan, M., and Jurs, P. C. (1980). Computer-assisted structure—activity studies of chemical carcinogens: A polycyclic aromatic hydrocarbon data set.Toxicol. Appl. Pharmacol.52, 294–312.
23.
22. Jerina, D.M., Lehr, R.E., Yagi, H., Hernandez, O., Dansete, P.M., Wislocki, P.G., Wood, A.W., Chang, R.L., Levin, W., and Conney, A. H. (1976). Mutagenicity of benzo(a)pyrene derivatives and the description of a quantum mechanical model that predicts the ease of carbonium ion formation from diol epoxides. In: de Serres, F.J., Fouts, J.R., Bend, J.R., and Philpot, R.M. eds: In Vitro Metabolic Activation in Mutagenesis Testing. Amsterdam: Elsevier/North Holland Biomedical Press, pp. 159–178.
24.
23. Ashby, J., and Tennant, R. W. (1988). Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested by the U.S. Nci/Ntp.Mutat. Res.204, 17–115.
25.
24. Klopman, G. (1984). Artificial intelligence approach to structure—activity studies. Computer automated structure evaluation of biological activity of organic molecules.J. Am. Chem. Soc.106, 7315–7321.
26.
25. Rosenkranz, H.S., Frierson, M.R., and Klopman, G. (1986). Use of structure—activity relationships in predicting carcinogenesis. In: Montesano, R., et al., eds. Long-Term and Short-Term Assays for Carcinogens: A Critical Appraisal. Iarc Scientific Publication No. 83. Lyon: International Agency for Research on Cancer, pp. 497–577.
27.
26. Klopman, G., And Mcgonigal, M. (1981). Computer simulation of physical-chemical properties of organic molecules. 1. Molecular system identification.J. Chem. Info. Comp. Sci.21, 48–52.
28.
27. Klopman, G., Namboodiri, K., and Schochet, M. (1985). Simple method of computing the partition coefficient.J. Comp. Chem.6(1), 28–38.
29.
28. Klopman, G., And Kalos, A. N., (1985). Causality in structure—activity studies.J. Comput. Chem.6, 492–506.
30.
29. Kier, L.D., Brusick, D.J., Auletta, A.E., Von Halle, E., Brown, M.M., Simmon, V.F., Dunkel, V., Mccann, J., Mortelmans, K., Prival, M., Rao, T.K., and Ray, V. (1986). The Salmonella typhimurium/mammalian microsomal assay.Mutat. Res.168, 69–240.
31.
30. Mitchell, C.S., Klopman, G., and Rosenkranz, H. S., (1986). Computer automated evaluation of mutagenicity and carcinogenicity of selected polycyclic aromatic hydrocarbons. In: Cooke, M., and Dennis, A.J., eds. Polynuclear Aromatic Hydrocarbons (Ninth International Symposium). Columbus, Oh: Battelle Press, pp. 611–624.
32.
31. Bigger, C.A.H., Tomaszewski, J.E., Andrews, A.W., and Dipple, A. (1980). Evaluation of metabolic activation of 7, 12-dimethylbenz(a)anthracene in vitro by Aroclor 1254-induced rat liver S-9 fraction.Cancer Res.40. 655–661.
33.
32. Wong, L.K., Wang, C.-L.A., and Daniel, F. B. (1980). Oxidative metabolites of 7, 12-dimethylbenz(a)anthracene. Further investigation of the K-region epoxideDrug Metab. Dispos.8, 28–33.
34.
33. Chou, M.W., Yang, S.K., Sydor, W., and Yang, C. S. (1981). Metabolism of 7, 12-dimethyl-benz(a)anthracene and 7-hydroxymethyl-12-methylbenz(a)anthracene by rat liver nuclei and microsomes.Cancer Res.41, 1559–1564.
35.
34. Yang, S.K., Mushtaq, M., and Chiu, P-L. (1985). Stereoselective metabolism and activations of polycyclic aromatic hydrocarbons. In: Polycyclic Aromatic Hydrocarbons. Acs Symposium Series, No. 283, pp. 19-34.
36.
35. Schoepe, K.-B., Friesel, H., Schurdak, M.E., Randerath, K., and Hecker, E. (1986). Comparative Dna binding of 7, 12-dimethylbenz(a)anthracene and some of its metabolites in mouse epidermis in vivo as revealed by the 32 P-postlabeling technique.Carcinogenesis7, 535–540.
37.
36. Cheng, S.C., Prakash, A.S., Hilton, B.D., Roman, J.M., Lee, H., Harvey, R.G., and Dipple, A. (1988). Characterization of Dna adducts from the Syn 3,4-dihydrodiol 1,2-Epoxide of 7. 12-dimethylbenz(a)anthracene (Dmba).Proc. Am. Assoc. Cancer Res.29, 92.
38.
37. Schmeiser, H., Dipple, A., Schurdak, M.E., Randerath, E., and Randerath, K. (1988). Comparison of 32 P-postlabeling and high pressure liquid chromatographic analyses for 7,12-dimethylbenz(a)anthracene-Dna adducts.Carcinogenesis9, 633–638.
